Elton John to Headline 2025 Curebound Concert for Cures at Petco Park

Since 2022, Curebound’s signature benefit concert series has raised more than $8.5 million to support innovative cancer research.

Curebound announced that legendary music artist, humanitarian, and global superstar, Elton John will headline the 2025 Concert for Cures on Friday, May 9, at Petco Park to raise awareness and funds for cutting-edge cancer research.

Since its launch in 2022, Concert for Cures has raised more than $8.5 million to support early-phase adult and pediatric cancer research among Southern California’s top research institutions. Previous headliners include Alicia Keys with the San Diego Symphony Orchestra and Ed Sheeran performing to sold-out crowds at the Rady Shell at Jacobs Park. This year, Concert for Cures expands to Petco Park for an extraordinary night of music, hope, and accelerated impact in the fight against cancer. To date, Curebound has invested over $45 million in collaborative research grants.

One of the top-selling solo artists of all time with more than 300 million records worldwide, Elton John has been honoured with six GRAMMYs, a Tony, two Oscars, induction into the Rock & Roll Hall of Fame and the Songwriters Hall of Fame, a Kennedy Center Honor, Legend of Live Award, and a knighthood from Her Majesty Queen Elizabeth II for “services to music and charitable services”. In January 2024, Elton John joined Hollywood’s elite group of EGOT winners after securing an EMMY Award for his historic Disney+ live concert special Elton John Live: Farewell from Dodger Stadium. Most recently, Elton and GRAMMY-winning singer-songwriter Brandi Carlile received an Academy Award nomination for Best Original Song for "Never Too Late," featured in his documentary "Elton John: Never Too Late," now streaming on Disney+. The song also appears on their upcoming collaborative studio album, "Who Believes in Angels?," set for release on April 4.

“Music has the power to unite people together behind a shared cause,” says Curebound CEO Anne Marbarger. “Every person in the world has been impacted by cancer and by working together, we will accelerate better prevention, detection, and treatment options for patients and families. The funds raised at Concert for Cures will help bring us one step closer to our vision of cures in our lifetime.”

Curebound corporate sponsors include: Clayco, Rady Children’s Hospital, UC San Diego, Salk Institute, Casa Dragones, ResMed, Lucier Family Foundation, Koman Family Foundation, JP Morgan Chase, UC San Diego Concierge Medicine, Schubach Aviation, Maravai Life Sciences, Ranch & Coast, Brand Napa Valley.

Special thanks to the Hood Family Foundation for their generous support.

Pre-sales begin March 3. Tickets go on sale at 10 a.m. on March 7 at curebound.org. For more information on Concert for Cures tickets, donations and sponsorship opportunities, please contact Mark Koczka at mark@curebound.org.

About Curebound: Curebound is a philanthropic organization that raises and invests strategic funding for cancer research with the power to save lives. Through collaborative grants, corporate partnerships, and targeted investments, Curebound aims to significantly accelerate better detection, treatments, and cures for cancer. Headquartered in the major U.S. biotech hub of San Diego, amid 3,000+ life sciences companies, leading health systems, and world-class research institutions, Curebound partners with and fosters connections between these organizations to forge interdisciplinary collaborations, encourage knowledge sharing, and fund pioneering cancer research. So far, Curebound has funded $45+ million in cancer research, awarding 140+ study grants for 20+ types of pediatric and adult cancers with one vision: cures in our lifetime. Join us - www.curebound.org. Curebound on Facebook / Instagram